(NVS) Novartis - Performance 12.4% in 12m
Compare NVS with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
55.36%
#14 in Group
Rel. Strength
76.19%
#1895 in Universe
Total Return 12m
12.38%
#40 in Group
Total Return 5y
62.50%
#26 in Group
P/E 17.9
55th Percentile in Group
P/E Forward 13.9
49th Percentile in Group
PEG 1.36
60th Percentile in Group
FCF Yield 5.98%
90th Percentile in Group
12m Total Return: NVS (12.4%) vs XLV (-5.9%)
5y Drawdown (Underwater) Chart
Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-3.75% | 164% | 412% | 58.1 | 44.4 | 0.61 | 48.6% | 9.63% |
| LLY NYSE Eli Lilly |
-2.54% | -4.17% | 393% | 67 | 36.6 | 1.33 | 58.2% | 18.9% |
| NVS NYSE Novartis |
4.67% | 12.4% | 62.5% | 17.9 | 13.9 | 1.36 | 8.40% | 9.2% |
| NOVN SW Novartis |
9.58% | 1.99% | 40% | 19.3 | 13.9 | 1.32 | 9.80% | 11.2% |
| SOBI ST Swedish Orphan Biovitrum |
21.6% | 4.1% | 49.3% | 25.6 | 20.9 | 1.61 | 16.1% | 29% |
| SAN PA Sanofi |
7.1% | 3.86% | 21.9% | 19.2 | 11.7 | 0.88 | -16.5% | 12.2% |
| IPN PA Ipsen |
9.35% | -14.1% | 58.7% | 23.3 | 9.65 | 0.69 | -6.40% | -6.33% |
| SUPN NASDAQ Supernus Pharmaceuticals |
-0.19% | 5.67% | 36% | 24.6 | 20.2 | 1.47 | -5.90% | -17% |
Performance Comparison: NVS vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for NVS
| Total Return (including Dividends) | NVS | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 4.67% | -4.38% | 2.87% |
| 3 Months | 5.39% | -8.96% | -6.42% |
| 12 Months | 12.38% | -5.92% | 9.87% |
| 5 Years | 62.50% | 41.93% | 107.51% |
| Trend Score (consistency of price movement) | NVS | XLV | S&P 500 |
| 1 Month | 48.8% | -9.7% | 89.4% |
| 3 Months | 57.8% | -77% | -72% |
| 12 Months | 13.2% | -30.6% | 49.3% |
| 5 Years | 87.7% | 89.6% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
| 1 Month | #89 | 9.47% | 1.75% |
| 3 Month | #30 | 15.8% | 12.6% |
| 12 Month | #40 | 19.4% | 2.28% |
| 5 Years | #26 | 14.5% | -21.7% |
FAQs
Does NVS Novartis outperforms the market?
Yes,
over the last 12 months NVS made 12.38%, while its related Sector, the Health Care Sector SPDR (XLV) made -5.92%.
Over the last 3 months NVS made 5.39%, while XLV made -8.96%.
Over the last 3 months NVS made 5.39%, while XLV made -8.96%.
Performance Comparison NVS vs Indeces and Sectors
NVS vs. Indices NVS is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -4.46% | 1.80% | 11.7% | 2.51% |
| US NASDAQ 100 | QQQ | -4.71% | -0.04% | 11.3% | 1.06% |
| US Dow Jones Industrial 30 | DIA | -4.74% | 3.06% | 12.8% | 6.01% |
| German DAX 40 | DAX | -6.58% | -14.6% | -13.9% | -12.7% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -5.12% | -1.60% | 12.5% | 6.75% |
| Hongkong Hang Seng | HSI | -7.98% | -11.5% | 2.23% | 0.29% |
| India NIFTY 50 | INDA | -2.07% | 2.39% | 9.82% | 10.1% |
| Brasil Bovespa | EWZ | -6.51% | -6.86% | 2.51% | 18.9% |
NVS vs. Sectors NVS is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -4.64% | 1.0% | 5.54% | -7.95% |
| Consumer Discretionary | XLY | -5.38% | 1.16% | 13.9% | -1.67% |
| Consumer Staples | XLP | -4.09% | 2.65% | 4.81% | 4.82% |
| Energy | XLE | -5.44% | 4.59% | 17.7% | 22.1% |
| Financial | XLF | -5.09% | -0.90% | 5.84% | -9.14% |
| Health Care | XLV | -0.67% | 9.05% | 17.0% | 18.3% |
| Industrial | XLI | -6.03% | -2.71% | 10.7% | 2.39% |
| Materials | XLB | -4.45% | -0.04% | 15.8% | 18.4% |
| Real Estate | XLRE | -4.13% | -1.45% | 9.34% | -1.08% |
| Technology | XLK | -5.35% | -2.07% | 14.0% | 5.38% |
| Utilities | XLU | -5.50% | -0.95% | 3.95% | -3.53% |
| Aerospace & Defense | XAR | -4.97% | -4.67% | 2.42% | -12.8% |
| Biotech | XBI | 3.62% | 2.65% | 32.8% | 26.4% |
| Homebuilder | XHB | -4.02% | 1.60% | 25.4% | 22.1% |
| Retail | XRT | -4.61% | 1.08% | 18.0% | 16.7% |